From Biotechnology to the Future of Medical Affairs

I didn't set out to work in Medical Affairs. I set out to understand how science actually reaches the people who need it — and that question kept pulling me forward, one step at a time, from a lab bench to a scientific exchange with a physician, and now toward a conversation about what AI can responsibly do for that exchange.

Biotechnology — the foundation

My scientific training in Biotechnology gave me the habit that still defines how I work: start from evidence, question the claim, verify before you communicate. That habit doesn't change when the tools do.

Pharma — learning the industry

Roles across AMGEN, PiLeJe, ESTEVE, Fresenius Kabi and Sanofi exposed me to different therapeutic areas, different organisational cultures and, increasingly, to the same core tension: how do you keep scientific engagement genuinely useful to healthcare professionals as the channels multiply?

Training — learning to explain, not just to know

Teaching — including sessions touching Artificial Intelligence, IoT, Telemedicine and Healthcare Innovation — taught me that expertise only creates value once it can be transferred. That's still the job of a Medical Science Liaison: translate evidence into something a clinician can use in the next five minutes of their day.

Digital — new channels, same discipline

As engagement moved online, I started paying attention to what "digital" actually changes in Medical Affairs — and what it doesn't. Omnichannel isn't a new discipline; it's the old discipline of scientific engagement, extended to more surfaces, with more discipline required to keep it rigorous.

Medical Affairs — where it all converges

Today, as a Medical Science Liaison in Vaccines, Medical Affairs is where the science, the stakeholder relationship and the strategy meet. It's also where I think the most interesting near-term change is happening — not despite AI, but because of how deliberately it needs to be introduced.

Artificial Intelligence — augment, don't replace

I explore AI in Medical Affairs from a practitioner's seat, not a vendor's. The question I keep asking is narrow and practical: does this tool make scientific judgement better, faster or more available — without compromising it? If not, it doesn't belong in the workflow yet.

The Future of Medical Affairs

That's the territory this website lives in — not a portfolio of what I've done, but a working exploration, in the open, of where Medical Affairs is going next.